NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced a grant to the Union for International Cancer Control (UICC) for a first-of-its-kind initiative to address the unique challenges facing metastatic breast cancer (MBC) patients. While great progress has been made in the management of breast cancer, it remains a significant and growing global health issue and patients are commonly diagnosed in the advanced stages of the disease.1,2 The Seeding Progress and Resources for the Cancer Community (SPARC): Metastatic Breast Cancer Challenge will provide grants to support initiatives worldwide that encourage sustainable change in addressing the specific needs of people living with metastatic breast cancer.
Aligned with the World Cancer Day ‘Not Beyond Us’ message, these grants aim to encourage implementation of solutions for treatment, care and support of metastatic breast cancer patients who often cope with their illness with a sense of isolation and stigma.3,4
Help employers find you! Check out all the jobs and post your resume.
